Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.31%221.64M | -1.37%221.14M | -3.07%877.74M | -0.10%215.69M | -9.12%219.08M | -2.62%218.77M | 0.15%224.2M | 4.29%905.51M | 0.42%215.91M | 11.75%241.06M |
| Cost of revenue | -3.12%467.22M | -1.60%482.26M | ||||||||
| Gross profit | -3.01%410.52M | 11.92%423.25M | ||||||||
| Operating expense | 4.59%404.07M | 5.74%386.35M | ||||||||
| Staff costs | ---- | ---- | 2.16%184.27M | ---- | ---- | ---- | ---- | 7.57%180.38M | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | 15.49%8.72M | ---- | ---- | ---- | ---- | 33.05%7.55M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | 16.63%8.14M | ---- | ---- | ---- | ---- | 35.97%6.98M | ---- | ---- |
| -General and administrative expense | ---- | ---- | 1.64%580.99K | ---- | ---- | ---- | ---- | 5.49%571.59K | ---- | ---- |
| Depreciation and amortization | ---- | ---- | 3.71%53.96M | ---- | ---- | ---- | ---- | -0.13%52.03M | ---- | ---- |
| -Depreciation | ---- | ---- | 3.71%53.96M | ---- | ---- | ---- | ---- | -0.13%52.03M | ---- | ---- |
| Rent and land expenses | ---- | ---- | 16.70%5.31K | ---- | ---- | ---- | ---- | 1,795.83%4.55K | ---- | ---- |
| Other operating expenses | ---- | ---- | 6.93%158.44M | ---- | ---- | ---- | ---- | 4.31%148.18M | ---- | ---- |
| Total other operating income | ---- | ---- | -25.92%1.33M | ---- | ---- | ---- | ---- | -15.90%1.79M | ---- | ---- |
| Operating profit | -100.96%-58K | -103.61%-315K | -82.54%6.44M | -2,187.58%-36.47M | -73.54%3.66M | 154.96%6.07M | 21.41%8.73M | 188.48%36.9M | -85.15%1.75M | 816.46%13.84M |
| Net non-operating interest income (expenses) | 12.28%-16.08M | -27.80%-18.33M | ||||||||
| Non-operating interest income | -72.16%27K | -72.16%27K | -15.06%403.56K | -35.26%101K | -37.82%97K | -5.83%97K | 10.23%97K | 56.66%475.1K | 74.73%156K | 62.50%156K |
| Non-operating interest expense | -11.51%3.94M | 5.94%3.85M | -12.35%16.48M | -4.90%4.31M | -10.98%4.08M | -9.04%4.45M | -24.73%3.64M | 28.40%18.81M | -4.82%4.53M | 5.57%4.58M |
| Net investment income | -73.71%-25.68M | -1,749.00%-14.78M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -231.84%-2.29M | 6,938.42%1.74M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 104.32%19.76K | -457.01K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 148.16%4.36M | -31.11%1.76M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | 36.04%-1.28M | ---- | ---- | ---- | ---- | 37.60%-2M | ---- | ---- |
| Less:Other special charges | ---- | ---- | -5,722.58%-3.01M | ---- | ---- | ---- | ---- | 134.95%53.49K | ---- | ---- |
| Less:Write off | ---- | ---- | -142.83%-79.46K | ---- | ---- | ---- | ---- | -76.86%185.53K | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -331.43%-3.97M | -179.83%-4.14M | -587.00%-33.23M | -1,448.97%-40.68M | -103.40%-320K | 171.19%1.72M | 112.23%5.19M | 3,830.04%6.82M | -129.77%-2.63M | 252.42%9.42M |
| Income tax | -26.98%1.13M | -44.51%1.43M | -94.08%870.51K | -155.00%-4.24M | -47.69%1.63M | -4.37%1.55M | 13.08%2.58M | 143.05%14.72M | 54.96%7.7M | 172.27%3.11M |
| Net income | -3,250.00%-5.1M | -313.45%-5.57M | -332.00%-34.1M | -252.78%-36.44M | -130.91%-1.95M | 104.02%162K | 1,481.82%2.61M | -34.21%-7.89M | -368.24%-10.33M | 186.11%6.3M |
| Net income continuous operations | -3,250.00%-5.1M | -313.45%-5.57M | -332.00%-34.1M | -252.78%-36.44M | -130.91%-1.95M | 104.02%162K | 1,481.82%2.61M | -34.21%-7.89M | -368.24%-10.33M | 186.11%6.3M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -3,250.00%-5.1M | -313.45%-5.57M | -332.00%-34.1M | -252.78%-36.44M | -130.91%-1.95M | 104.02%162K | 1,481.82%2.61M | -34.21%-7.89M | -368.24%-10.33M | 186.11%6.3M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -3,250.00%-5.1M | -313.45%-5.57M | -332.00%-34.1M | -252.78%-36.44M | -130.91%-1.95M | 104.02%162K | 1,481.82%2.61M | -34.21%-7.89M | -368.24%-10.33M | 186.11%6.3M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -4,600.00%-0.0045 | -317.39%-0.005 | -334.29%-0.0304 | -252.17%-0.0324 | -130.36%-0.0017 | 102.78%0.0001 | 2,200.00%0.0023 | -34.62%-0.007 | -362.86%-0.0092 | 186.15%0.0056 |
| Diluted earnings per share | -4,600.00%-0.0045 | -317.39%-0.005 | -334.29%-0.0304 | -252.17%-0.0324 | -130.36%-0.0017 | 102.78%0.0001 | 2,200.00%0.0023 | -34.62%-0.007 | -362.86%-0.0092 | 186.15%0.0056 |
| Dividend per share | 0 | 0 | -50.00%0.004 | 0 | -50.00%0.004 | 0 | 0 | 0.00%0.008 | 0 | 0.008 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.